标题
Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 8, Pages 1987
出版商
MDPI AG
发表日期
2020-04-29
DOI
10.3390/molecules25081987
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice
- (2018) Annie Hasib et al. PEPTIDES
- Precision medicine in diabetes prevention, classification and management
- (2018) Fangying Xie et al. Journal of Diabetes Investigation
- Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors
- (2018) Oleg G. Chepurny et al. Scientific Reports
- Precision medicine in the management of type 2 diabetes
- (2018) Anna L Gloyn et al. Lancet Diabetes & Endocrinology
- An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications
- (2018) Rosanna Maccari et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Gut microbiome and type 2 diabetes: where we are and where to go?
- (2018) Sapna Sharma et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Physiological role of adiponectin in different tissues: a review
- (2018) S. Esmaili et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes
- (2017) Robert S. Busch et al. POSTGRADUATE MEDICINE
- An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes
- (2017) Ajda Ota et al. Frontiers in Pharmacology
- Genes, Genetics, and Environment in Type 2 Diabetes: Implication in Personalized Medicine
- (2016) Nabodita Kaul et al. DNA AND CELL BIOLOGY
- The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones
- (2016) Claire L Meek et al. PEPTIDES
- Deciphering Metabolic Messages From the Gut Drives Therapeutic Innovation: The 2014 Banting Lecture
- (2015) Daniel J. Drucker DIABETES
- SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
- (2015) Silvio E Inzucchi et al. Diabetes & Vascular Disease Research
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- The role of fatty acids in insulin resistance
- (2015) Barry Sears et al. Lipids in Health and Disease
- Glucagon and Type 2 Diabetes: the Return of the Alpha Cell
- (2014) Asger Lund et al. Current Diabetes Reports
- Coinfusion of Low-Dose GLP-1 and Glucagon in Man Results in a Reduction in Food Intake
- (2014) Jaimini Cegla et al. DIABETES
- Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus
- (2014) Aisling M. Lynch et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
- (2014) Yanling Wu et al. International Journal of Medical Sciences
- Genetics of Type 2 Diabetes: Insights into the Pathogenesis and Its Clinical Application
- (2014) Xue Sun et al. Biomed Research International
- Use of systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans
- (2014) Yasong Lu et al. Frontiers in Pharmacology
- Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
- (2014) Yoshifumi Saisho Journal of Clinical Medicine
- Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
- (2013) Theodore Kelesidis ANNALS OF INTERNAL MEDICINE
- Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1
- (2013) V. Pathak et al. DIABETES OBESITY & METABOLISM
- A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice
- (2013) V. K. Bhat et al. DIABETOLOGIA
- Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala
- (2013) J A Parker et al. INTERNATIONAL JOURNAL OF OBESITY
- Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
- (2013) Sharon A. Sadry et al. Nature Reviews Endocrinology
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents
- (2012) Jonathan W. Day et al. BIOPOLYMERS
- LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
- (2012) B Zambrowicz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Why Do SGLT2 Inhibitors Inhibit Only 30-50% of Renal Glucose Reabsorption in Humans?
- (2012) J. Liu et al. DIABETES
- Unraveling oxyntomodulin, GLP1's enigmatic brother
- (2012) Alessandro Pocai JOURNAL OF ENDOCRINOLOGY
- GLP-1 receptor agonists and HBA1ctarget of
- (2011) K. Esposito et al. CURRENT MEDICAL RESEARCH AND OPINION
- α-Glucosidase Inhibition Properties of Cucurbitane-Type Triterpene Glycosides from the Fruits of Momordica charantia
- (2010) Nguyen Xuan Nhiem et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Genomics, Type 2 Diabetes, and Obesity
- (2010) Mark I. McCarthy NEW ENGLAND JOURNAL OF MEDICINE
- The emerging genetics of type 2 diabetes
- (2010) Amélie Bonnefond et al. TRENDS IN MOLECULAR MEDICINE
- On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans
- (2009) Meena Asmar et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats
- (2009) Hyun Joo Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population
- (2008) Kirsti Jalovaara et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Antiobesity effects of wild ginseng (Panax ginsengC.A. Meyer) mediated by PPAR-γ, GLUT4 and LPL in ob/ob mice
- (2008) Mohammad Lalmoddin Mollah et al. PHYTOTHERAPY RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started